• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 68 of 100
The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal
FinanceBayer Shares Rise After It Ups Sales Targets for Top-Selling Drugs
By ReutersSeptember 20, 2016
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
HealthNovartis Says MS Drug Cut Risk of Disability Advance in Study
By ReutersSeptember 17, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthA Minnesota Doctor Is Trying Get a $50 EpiPen Alternative to Market
By Sy MukherjeeSeptember 15, 2016
Meet the Federal Government’s Pot Dealer
HealthMeet the Federal Government’s Pot Dealer
By Andrew Joseph and STAT NewsSeptember 15, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
HealthMylan Reportedly Paid Its Executives More Than Bigger Rivals
By Tom Huddleston Jr.September 14, 2016
Mylan EpiPen; epinephrine injection, 0.3 mg
HealthThis Vote Could Finally Make a Difference in Crazy Drug Prices
By Sy MukherjeeSeptember 14, 2016
GERMANY-AGRICULTURE-BAYER-MONSANTO-MERGER
FinanceBayer, Monsanto Agree to Merge in $66 Billion Deal
By Reuters and Fortune EditorsSeptember 14, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthMylan Agrees to Hand Over EpiPen Documents to Congress
By Sy MukherjeeSeptember 13, 2016
General Economy Images In Bangladesh
HealthU.S. Justice Department Subpoenas Taro Over Generic Drug Pricing
By ReutersSeptember 11, 2016
CNBC Events
HealthAllergan’s CEO Just Pledged a ‘Social Contract’ With Patients on Drug Prices
By Sy MukherjeeSeptember 6, 2016
One analyst thinks Mylan's EpiPen price hike ties back to its executive incentive plans.
HealthMylan’s EpiPen Problems Just Got a Whole Lot Worse
By Sy Mukherjee and ReutersSeptember 6, 2016
PillPack
FinancePillPack Is Raising More Money to Take On Pharmacies
By Dan PrimackSeptember 6, 2016
Biogen Drug Shows Early Promise against Alzheimer’s Disease
TechBiogen Drug Shows Early Promise against Alzheimer’s Disease
By David Z. MorrisSeptember 3, 2016
Democratic Presidential candidate and former U.S. Secretary of State Hillary Clinton Campaigns In Iowa
LeadershipHillary Clinton Says You Won’t See Price Hikes On Life-Saving Drugs if She’s Elected
By ReutersSeptember 2, 2016
FRANCE-POLITICS-INDUSTRY
HealthU.S. Headwinds Force Change of CEO at Novo Nordisk
By ReutersSeptember 1, 2016
1...
  • 66
  • 67
  • 68
  • 69
  • 70
...100
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethicplaceholder alt text
By Orianna Rosa RoyleJune 24, 2026
Success
Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurantsplaceholder alt text
By Orianna Rosa RoyleJune 25, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.